Table 1.
Commonly up-regulated genes in both RCC tissue samples
| Accession number | Gene name* | Avg. fold-change |
| M95167 | Dopamine transporter (SLC6A3) | 55.6 |
| HG3044-HT3742 | Fibronectin 1 1,2,4 | 44.2 |
| U29195 | Neuronal pentraxin II (NPTX2) | 38.6 |
| X51441 | Serum amyloid A (SAA) (_s_at)1 | 37.4 |
| J03474 | Serum amyloid A (SAA)1 | 34.4 |
| U90546 | Butyrophilin (BTF4) | 32.5 |
| X51441 | Serum amyloid A (SAA) (_at)1 | 29.2 |
| M77349 | Transforming growth factor-beta induced gene product (BIGH3)1,3,4 | 28.4 |
| X51956 | Enolase2 (ENO2)2,4 | 26.2 |
| U10485 | Lymphoid-restricted membrane protein (Jaw1) | 25.9 |
| D88667 | Cerebroside sulfotransferase | 21.3 |
| U17077 | BENE4 | 17.3 |
| M10321 | von Willebrand factor (vWF)1,2,3 | 15.5 |
| U45878 | Inhibitor of apoptosis protein 1 | 14.4 |
| X06256 | Fibronectin receptor alpha subunit1 | 12.8 |
| L27624 | Tissue factor pathway inhibitor-2 | 12.1 |
| M20902 | Apolipoprotein C-I (VLDL)1,2,4 | 12.0 |
| M24766 | Alpha-2 collagen type IV (COL4A2)1,4 | 11.8 |
| X90908 | I-15P (I-BABP) | 11.7 |
| M15796 | Cyclin4 | 11.5 |
| U52101 | YMP | 11.4 |
| X66839 | MaTu MN for p54/58N | 10.7 |
| M35878 | Insulin-like growth factor-binding protein-31,2,4 | 10.0 |
| U24577 | LDL-phospholipase A2 | 9.4 |
| L34155 | Laminin-related protein (LamA3) | 9.2 |
| M16591 | Hemopoietic cell protein-tyrosine kinase (HCK)4 | 9.1 |
| U60644 | HU-K44 | 8.9 |
| X91911 | RTVP-11,4 | 8.4 |
| M94250 | Retinoic acid inducible factor (MK) | 6.6 |
| X07743 | Pleckstrin (P47)4 | 6.3 |
| X51405 | Carboxypeptidase E (EC 3.4.17.10) | 6.0 |
| X02761 | Fibronectin 11,2,4 | 5.9 |
*Over-expression also reported in clear cell RCC by 1Boer et al., 2Takahashi et al., 3Young et al., and/or 4Higgins et al.